how safe is hers semaglutide Hims & falls 8% as FDA issues warning letter over compounded weight loss drug Thinking About Using Hers' Weight

Teva Pharmaceuticals (Teva) has launched the first generic glucagon-like peptide-1 (GLP-1) drug for weight loss in adults and adolescents

Patients with genetic markers suggesting stronger GLP1R or GIPR sensitivity may respond well to either semaglutide or tirzepatide formulations, while FTO or MC4R variants offer additional metabolic insight

In clinical trials reported on the drugs label, 15.8% of patients taking the 5 mg dose and 20.3% of patients taking the 1 mg dose reported nausea

At 80 weeks, results showed that all three doses of retatrutide met the primary and key secondary end points for obesity, with clinically meaningful weight loss in all three groups

How do I contact FeelGood if I have questions

home preparation does not